Vascular pathology as a result of drug-eluting stents.
作者信息
Bennett Martin R
出版信息
Heart. 2007 Aug;93(8):895-6. doi: 10.1136/hrt.2006.113894.
Abstract
摘要
相似文献
1
Vascular pathology as a result of drug-eluting stents.药物洗脱支架导致的血管病理学
Heart. 2007 Aug;93(8):895-6. doi: 10.1136/hrt.2006.113894.
2
[Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].西罗莫司洗脱支架与紫杉醇洗脱支架——试验证实临床结果存在差异
Kardiol Pol. 2005 Nov;63(5):574-6; discussion 577.
3
Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.在小鼠动脉粥样硬化基础上的再狭窄模型中，西罗莫司和紫杉醇局部给药后引发不同的血管病理反应。
Heart. 2007 Aug;93(8):922-7. doi: 10.1136/hrt.2006.102244. Epub 2007 Apr 20.
4
Biological aspects of radiation and drug-eluting stents for the prevention of restenosis.用于预防再狭窄的放射性和药物洗脱支架的生物学特性
Cardiovasc Res. 2004 Jul 1;63(1):22-30. doi: 10.1016/j.cardiores.2004.02.001.
5
Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.促进血管再生作为基于传统血管成形术干预的替代方法。
Endothelium. 2006 Nov-Dec;13(6):431-9. doi: 10.1080/10623320601066812.
6
Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future.药物洗脱支架与糖蛋白IIb/IIIa抑制剂：未来的联合治疗方案。
Am Heart J. 2003 Oct;146(4 Suppl):S13-7. doi: 10.1016/j.ahj.2003.09.004.
7
Stent fracture-unusual cause of DES restenosis.支架断裂——药物洗脱支架再狭窄的罕见原因。
Catheter Cardiovasc Interv. 2007 Jun 1;69(7):993-4. doi: 10.1002/ccd.21241.
8
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.药物洗脱支架的长期安全性和有效性：REAL（艾米利亚-罗马涅血管成形术注册研究）多中心注册研究的两年结果。
Circulation. 2007 Jun 26;115(25):3181-8. doi: 10.1161/CIRCULATIONAHA.106.667592. Epub 2007 Jun 11.
9
Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.紫杉醇球囊涂层，一种预防和治疗再狭窄的新方法。
Circulation. 2004 Aug 17;110(7):810-4. doi: 10.1161/01.CIR.0000138929.71660.E0. Epub 2004 Aug 9.
10
[Drug-eluting coronary stents].
Orv Hetil. 2006 Oct 29;147(43):2059-66.
本文引用的文献
1
Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.在小鼠动脉粥样硬化基础上的再狭窄模型中，西罗莫司和紫杉醇局部给药后引发不同的血管病理反应。
Heart. 2007 Aug;93(8):922-7. doi: 10.1136/hrt.2006.102244. Epub 2007 Apr 20.
2
Cause of death with bare metal and sirolimus-eluting stents.裸金属支架和西罗莫司洗脱支架的死亡原因。
Eur Heart J. 2006 Dec;27(23):2815-22. doi: 10.1093/eurheartj/ehl385. Epub 2006 Nov 15.
3
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.药物洗脱支架在人体中的病理学：愈合延迟和晚期血栓形成风险。
J Am Coll Cardiol. 2006 Jul 4;48(1):193-202. doi: 10.1016/j.jacc.2006.03.042. Epub 2006 May 5.
4
Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.西罗莫司洗脱支架的新生内膜覆盖不完全：血管内镜检查结果
J Am Coll Cardiol. 2006 May 16;47(10):2108-11. doi: 10.1016/j.jacc.2005.11.092. Epub 2006 Apr 4.
5
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.经血管造影证实的西罗莫司洗脱支架和紫杉醇洗脱支架血栓形成的相关因素及长期预后
Circulation. 2006 Feb 28;113(8):1108-13. doi: 10.1161/CIRCULATIONAHA.105.600155. Epub 2006 Feb 20.
6
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.西罗莫司或紫杉醇洗脱支架重叠部位延迟愈合和持续性炎症的差异反应
Circulation. 2005 Jul 12;112(2):270-8. doi: 10.1161/CIRCULATIONAHA.104.508937. Epub 2005 Jul 5.
7
Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis).经皮冠状动脉介入治疗中药物洗脱支架与裸金属支架的比较（一项荟萃分析）
Am J Cardiol. 2005 May 15;95(10):1146-52. doi: 10.1016/j.amjcard.2005.01.040.
8
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.药物洗脱支架血栓形成：一项纳入10项随机研究的汇总分析结果
J Am Coll Cardiol. 2005 Mar 15;45(6):954-9. doi: 10.1016/j.jacc.2004.11.065.
9
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.裸金属支架、西罗莫司支架或紫杉醇支架植入后血栓性支架闭塞的30天发生率及6个月临床结局
J Am Coll Cardiol. 2005 Mar 15;45(6):947-53. doi: 10.1016/j.jacc.2004.09.079.
10
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.停用抗血小板治疗后药物洗脱冠状动脉支架的晚期血栓形成。
Lancet. 2004;364(9444):1519-21. doi: 10.1016/S0140-6736(04)17275-9.
Zotero 插件